Key result
Among patients undergoing coronary atherectomy, diabetes mellitus was associated with similar in-hospital mortality compared to non-diabetic patients (2.24% vs 3.29%, p=0.27).
Why the study?
Patients with diabetes mellitus have higher complication rates after PCI, but the incidence of major adverse cardiovascular events after atherectomy in this population needed assessment.
Does diabetes mellitus worsen in-hospital outcomes and complications in patients undergoing orbital/rotational coronary atherectomy?
Cohort (n=6,184)
Yes
Does diabetes mellitus worsen in-hospital outcomes and complications in patients undergoing orbital/rotational coronary atherectomy?
Absolute Event Rate: 2.24% vs 3.29%
p-value: p=0.27
Coronary atherectomy is a safe option for severely calcified plaques in diabetic patients, with in-hospital outcomes comparable to non-diabetic patients.
Supports comparable atherectomy safety in diabetics; hypothesis-generating and should not yet change practice.
Background Atherectomy (AT) using an orbital/rotational system is useful in altering calcified plaque thereby facilitating stent placement and optimal stent expansion. Patients with diabetes mellitus (DM) are known to have a higher rate of complications after percutaneous coronary intervention. We aimed to assess the incidence of major adverse cardiovascular events after atherectomy in the diabetic population using a nationwide inpatient sample (NIS). Methods NIS-HCUP database from 2015–2017 was used to identify patients who underwent atherectomy. A cohort of patients with and without diabetes was identified. Demographics, in-hospital outcomes, complications in both groups were compared. Statistical significance was assigned at p<0.05. Results Out of 6184 patients who underwent AT, 3134 (50.6%) patients had DM. Baseline characteristics have been outlined in the table below. Complications were comparable between the two groups except for higher incidence of post-procedure VTE in Diabetic patients. In-hospital mortality was lower among patients with DM (2.24% vs 3.29%, p-0.27), while the mean length of stay (5.92 vs 4.91 days, p-0.002) and the hospitalization charges ($165118.4 vs 151226, p-0.04) were higher, but this difference in length of stay and hospitalization charges were nullified on multivariate regression. Conclusion Our study suggests that an AT for severely calcified plaque in the coronary artery is a safe option in patients with DM with comparable in-hospital complications and outcomes to non-DM patients. Funding Acknowledgement Type of funding sources: None.
No takes yet. Share an insight, caveat, or question.
Kurpad et al. (2021) conducted a cohort in Severely calcified coronary artery plaque requiring atherectomy (n=6,184). Diabetes mellitus vs. Non-diabetic patients was evaluated on In-hospital mortality (p=0.27). Among patients undergoing coronary atherectomy, diabetes mellitus was associated with similar in-hospital mortality compared to non-diabetic patients (2.24% vs 3.29%, p=0.27).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: